nodes	percent_of_prediction	percent_of_DWPC	metapath
Betamethasone—systemic lupus erythematosus—focal segmental glomerulosclerosis	0.873	1	CtDrD
Betamethasone—PLA2G1B—nephron—focal segmental glomerulosclerosis	0.0187	0.379	CbGeAlD
Betamethasone—NR3C2—nephron—focal segmental glomerulosclerosis	0.00928	0.188	CbGeAlD
Betamethasone—PTGS2—nephron—focal segmental glomerulosclerosis	0.00431	0.0871	CbGeAlD
Betamethasone—PLA2G1B—kidney—focal segmental glomerulosclerosis	0.00356	0.0719	CbGeAlD
Betamethasone—Benign intracranial hypertension—Cyclosporine—focal segmental glomerulosclerosis	0.00303	0.0436	CcSEcCtD
Betamethasone—Papilloedema—Cyclosporine—focal segmental glomerulosclerosis	0.0028	0.0403	CcSEcCtD
Betamethasone—Atrophy—Cyclosporine—focal segmental glomerulosclerosis	0.00274	0.0394	CcSEcCtD
Betamethasone—Sensation of foreign body—Cyclosporine—focal segmental glomerulosclerosis	0.00274	0.0394	CcSEcCtD
Betamethasone—Hypertrichosis—Cyclosporine—focal segmental glomerulosclerosis	0.00234	0.0337	CcSEcCtD
Betamethasone—PTGS2—endothelium—focal segmental glomerulosclerosis	0.00203	0.0411	CbGeAlD
Betamethasone—Conjunctival hyperaemia—Cyclosporine—focal segmental glomerulosclerosis	0.00203	0.0292	CcSEcCtD
Betamethasone—NR3C2—nephron tubule—focal segmental glomerulosclerosis	0.002	0.0405	CbGeAlD
Betamethasone—Pancreatitis acute—Cyclosporine—focal segmental glomerulosclerosis	0.00193	0.0278	CcSEcCtD
Betamethasone—Trauma—Cyclosporine—focal segmental glomerulosclerosis	0.00187	0.0269	CcSEcCtD
Betamethasone—NR3C2—kidney—focal segmental glomerulosclerosis	0.00176	0.0356	CbGeAlD
Betamethasone—NR3C2—cortex of kidney—focal segmental glomerulosclerosis	0.00172	0.0347	CbGeAlD
Betamethasone—Multiple fractures—Cyclosporine—focal segmental glomerulosclerosis	0.00153	0.0221	CcSEcCtD
Betamethasone—Fracture—Cyclosporine—focal segmental glomerulosclerosis	0.00153	0.0221	CcSEcCtD
Betamethasone—Hirsutism—Cyclosporine—focal segmental glomerulosclerosis	0.00153	0.0221	CcSEcCtD
Betamethasone—Optic neuritis—Cyclosporine—focal segmental glomerulosclerosis	0.00145	0.0209	CcSEcCtD
Betamethasone—Folliculitis—Cyclosporine—focal segmental glomerulosclerosis	0.00142	0.0204	CcSEcCtD
Betamethasone—Peptic ulcer—Cyclosporine—focal segmental glomerulosclerosis	0.00133	0.0192	CcSEcCtD
Betamethasone—Myopathy—Cyclosporine—focal segmental glomerulosclerosis	0.00127	0.0183	CcSEcCtD
Betamethasone—Fungal infection—Cyclosporine—focal segmental glomerulosclerosis	0.00115	0.0166	CcSEcCtD
Betamethasone—Abscess—Cyclosporine—focal segmental glomerulosclerosis	0.00113	0.0162	CcSEcCtD
Betamethasone—Tingling sensation—Cyclosporine—focal segmental glomerulosclerosis	0.00111	0.016	CcSEcCtD
Betamethasone—Stinging—Cyclosporine—focal segmental glomerulosclerosis	0.0011	0.0158	CcSEcCtD
Betamethasone—NR3C1—nephron tubule—focal segmental glomerulosclerosis	0.00107	0.0217	CbGeAlD
Betamethasone—Acne—Cyclosporine—focal segmental glomerulosclerosis	0.00106	0.0152	CcSEcCtD
Betamethasone—Amenorrhoea—Cyclosporine—focal segmental glomerulosclerosis	0.00101	0.0146	CcSEcCtD
Betamethasone—NR3C2—ACE Inhibitor Pathway—AGTR2—focal segmental glomerulosclerosis	0.000998	0.136	CbGpPWpGaD
Betamethasone—Arthropathy—Cyclosporine—focal segmental glomerulosclerosis	0.00098	0.0141	CcSEcCtD
Betamethasone—Herpes simplex—Cyclosporine—focal segmental glomerulosclerosis	0.000967	0.0139	CcSEcCtD
Betamethasone—NR3C1—kidney—focal segmental glomerulosclerosis	0.000945	0.0191	CbGeAlD
Betamethasone—Cataract—Cyclosporine—focal segmental glomerulosclerosis	0.000936	0.0135	CcSEcCtD
Betamethasone—NR3C1—cortex of kidney—focal segmental glomerulosclerosis	0.00092	0.0186	CbGeAlD
Betamethasone—Hiccups—Cyclosporine—focal segmental glomerulosclerosis	0.000891	0.0128	CcSEcCtD
Betamethasone—NR3C2—ACE Inhibitor Pathway—ACE—focal segmental glomerulosclerosis	0.000852	0.116	CbGpPWpGaD
Betamethasone—Fluid retention—Cyclosporine—focal segmental glomerulosclerosis	0.000846	0.0122	CcSEcCtD
Betamethasone—Neuropathy—Cyclosporine—focal segmental glomerulosclerosis	0.000837	0.012	CcSEcCtD
Betamethasone—PTGS2—kidney—focal segmental glomerulosclerosis	0.000818	0.0165	CbGeAlD
Betamethasone—Oesophagitis—Cyclosporine—focal segmental glomerulosclerosis	0.000815	0.0117	CcSEcCtD
Betamethasone—NR3C2—ACE Inhibitor Pathway—AGTR1—focal segmental glomerulosclerosis	0.000768	0.104	CbGpPWpGaD
Betamethasone—Diabetes mellitus—Cyclosporine—focal segmental glomerulosclerosis	0.000744	0.0107	CcSEcCtD
Betamethasone—Eye pain—Cyclosporine—focal segmental glomerulosclerosis	0.000717	0.0103	CcSEcCtD
Betamethasone—CYP3A4—kidney—focal segmental glomerulosclerosis	0.000714	0.0144	CbGeAlD
Betamethasone—Injury—Cyclosporine—focal segmental glomerulosclerosis	0.000704	0.0101	CcSEcCtD
Betamethasone—Increased appetite—Cyclosporine—focal segmental glomerulosclerosis	0.000689	0.00991	CcSEcCtD
Betamethasone—Visual disturbance—Cyclosporine—focal segmental glomerulosclerosis	0.000683	0.00982	CcSEcCtD
Betamethasone—Dermatitis bullous—Cyclosporine—focal segmental glomerulosclerosis	0.000677	0.00974	CcSEcCtD
Betamethasone—Anaphylactoid reaction—Cyclosporine—focal segmental glomerulosclerosis	0.000669	0.00962	CcSEcCtD
Betamethasone—Cardiac failure—Cyclosporine—focal segmental glomerulosclerosis	0.000663	0.00954	CcSEcCtD
Betamethasone—Lethargy—Cyclosporine—focal segmental glomerulosclerosis	0.00066	0.0095	CcSEcCtD
Betamethasone—Osteoarthritis—Cyclosporine—focal segmental glomerulosclerosis	0.000647	0.00931	CcSEcCtD
Betamethasone—Affect lability—Cyclosporine—focal segmental glomerulosclerosis	0.000637	0.00916	CcSEcCtD
Betamethasone—Migraine—Cyclosporine—focal segmental glomerulosclerosis	0.000637	0.00916	CcSEcCtD
Betamethasone—Mood swings—Cyclosporine—focal segmental glomerulosclerosis	0.000613	0.00882	CcSEcCtD
Betamethasone—Dry skin—Cyclosporine—focal segmental glomerulosclerosis	0.000593	0.00853	CcSEcCtD
Betamethasone—ABCB1—nephron tubule—focal segmental glomerulosclerosis	0.000575	0.0116	CbGeAlD
Betamethasone—Muscular weakness—Cyclosporine—focal segmental glomerulosclerosis	0.000571	0.00821	CcSEcCtD
Betamethasone—Sweating increased—Cyclosporine—focal segmental glomerulosclerosis	0.000545	0.00784	CcSEcCtD
Betamethasone—NR3C2—ACE Inhibitor Pathway—AGT—focal segmental glomerulosclerosis	0.00054	0.0735	CbGpPWpGaD
Betamethasone—ABCB1—Cyclosporine—focal segmental glomerulosclerosis	0.000524	0.625	CbGbCtD
Betamethasone—Weight increased—Cyclosporine—focal segmental glomerulosclerosis	0.000509	0.00732	CcSEcCtD
Betamethasone—Weight decreased—Cyclosporine—focal segmental glomerulosclerosis	0.000506	0.00728	CcSEcCtD
Betamethasone—ABCB1—kidney—focal segmental glomerulosclerosis	0.000506	0.0102	CbGeAlD
Betamethasone—Hyperglycaemia—Cyclosporine—focal segmental glomerulosclerosis	0.000504	0.00726	CcSEcCtD
Betamethasone—ABCB1—cortex of kidney—focal segmental glomerulosclerosis	0.000492	0.00996	CbGeAlD
Betamethasone—Acute coronary syndrome—Cyclosporine—focal segmental glomerulosclerosis	0.000492	0.00707	CcSEcCtD
Betamethasone—Myocardial infarction—Cyclosporine—focal segmental glomerulosclerosis	0.000489	0.00703	CcSEcCtD
Betamethasone—Neuropathy peripheral—Cyclosporine—focal segmental glomerulosclerosis	0.000489	0.00703	CcSEcCtD
Betamethasone—Conjunctivitis—Cyclosporine—focal segmental glomerulosclerosis	0.000485	0.00697	CcSEcCtD
Betamethasone—Haemoglobin—Cyclosporine—focal segmental glomerulosclerosis	0.00045	0.00647	CcSEcCtD
Betamethasone—Haemorrhage—Cyclosporine—focal segmental glomerulosclerosis	0.000448	0.00644	CcSEcCtD
Betamethasone—Visual impairment—Cyclosporine—focal segmental glomerulosclerosis	0.000431	0.00621	CcSEcCtD
Betamethasone—Angiopathy—Cyclosporine—focal segmental glomerulosclerosis	0.000406	0.00584	CcSEcCtD
Betamethasone—Arrhythmia—Cyclosporine—focal segmental glomerulosclerosis	0.0004	0.00575	CcSEcCtD
Betamethasone—Alopecia—Cyclosporine—focal segmental glomerulosclerosis	0.000396	0.00569	CcSEcCtD
Betamethasone—PTGS2—Overview of nanoparticle effects—COL4A1—focal segmental glomerulosclerosis	0.000394	0.0536	CbGpPWpGaD
Betamethasone—NR3C1—Adipogenesis—ZMPSTE24—focal segmental glomerulosclerosis	0.000378	0.0514	CbGpPWpGaD
Betamethasone—Ill-defined disorder—Cyclosporine—focal segmental glomerulosclerosis	0.000362	0.0052	CcSEcCtD
Betamethasone—Angioedema—Cyclosporine—focal segmental glomerulosclerosis	0.000356	0.00512	CcSEcCtD
Betamethasone—Malaise—Cyclosporine—focal segmental glomerulosclerosis	0.000351	0.00506	CcSEcCtD
Betamethasone—Vertigo—Cyclosporine—focal segmental glomerulosclerosis	0.00035	0.00504	CcSEcCtD
Betamethasone—Convulsion—Cyclosporine—focal segmental glomerulosclerosis	0.000338	0.00486	CcSEcCtD
Betamethasone—Hypertension—Cyclosporine—focal segmental glomerulosclerosis	0.000336	0.00484	CcSEcCtD
Betamethasone—Myalgia—Cyclosporine—focal segmental glomerulosclerosis	0.000332	0.00477	CcSEcCtD
Betamethasone—Anxiety—Cyclosporine—focal segmental glomerulosclerosis	0.000331	0.00476	CcSEcCtD
Betamethasone—Discomfort—Cyclosporine—focal segmental glomerulosclerosis	0.000328	0.00472	CcSEcCtD
Betamethasone—Anaphylactic shock—Cyclosporine—focal segmental glomerulosclerosis	0.000318	0.00458	CcSEcCtD
Betamethasone—Oedema—Cyclosporine—focal segmental glomerulosclerosis	0.000318	0.00458	CcSEcCtD
Betamethasone—Infection—Cyclosporine—focal segmental glomerulosclerosis	0.000316	0.00455	CcSEcCtD
Betamethasone—CYP3A4—Cyclosporine—focal segmental glomerulosclerosis	0.000314	0.375	CbGbCtD
Betamethasone—Nervous system disorder—Cyclosporine—focal segmental glomerulosclerosis	0.000312	0.00449	CcSEcCtD
Betamethasone—Thrombocytopenia—Cyclosporine—focal segmental glomerulosclerosis	0.000311	0.00448	CcSEcCtD
Betamethasone—Hyperhidrosis—Cyclosporine—focal segmental glomerulosclerosis	0.000307	0.00442	CcSEcCtD
Betamethasone—Anorexia—Cyclosporine—focal segmental glomerulosclerosis	0.000303	0.00436	CcSEcCtD
Betamethasone—Musculoskeletal discomfort—Cyclosporine—focal segmental glomerulosclerosis	0.00029	0.00417	CcSEcCtD
Betamethasone—Insomnia—Cyclosporine—focal segmental glomerulosclerosis	0.000288	0.00414	CcSEcCtD
Betamethasone—Paraesthesia—Cyclosporine—focal segmental glomerulosclerosis	0.000286	0.00411	CcSEcCtD
Betamethasone—Dyspepsia—Cyclosporine—focal segmental glomerulosclerosis	0.00028	0.00403	CcSEcCtD
Betamethasone—Decreased appetite—Cyclosporine—focal segmental glomerulosclerosis	0.000276	0.00398	CcSEcCtD
Betamethasone—Gastrointestinal disorder—Cyclosporine—focal segmental glomerulosclerosis	0.000275	0.00395	CcSEcCtD
Betamethasone—Fatigue—Cyclosporine—focal segmental glomerulosclerosis	0.000274	0.00394	CcSEcCtD
Betamethasone—Pain—Cyclosporine—focal segmental glomerulosclerosis	0.000272	0.00391	CcSEcCtD
Betamethasone—NR3C2—ACE Inhibitor Pathway—TGFB1—focal segmental glomerulosclerosis	0.000262	0.0357	CbGpPWpGaD
Betamethasone—Feeling abnormal—Cyclosporine—focal segmental glomerulosclerosis	0.000262	0.00377	CcSEcCtD
Betamethasone—Gastrointestinal pain—Cyclosporine—focal segmental glomerulosclerosis	0.00026	0.00374	CcSEcCtD
Betamethasone—Urticaria—Cyclosporine—focal segmental glomerulosclerosis	0.000253	0.00364	CcSEcCtD
Betamethasone—Body temperature increased—Cyclosporine—focal segmental glomerulosclerosis	0.000251	0.00362	CcSEcCtD
Betamethasone—Abdominal pain—Cyclosporine—focal segmental glomerulosclerosis	0.000251	0.00362	CcSEcCtD
Betamethasone—Asthenia—Cyclosporine—focal segmental glomerulosclerosis	0.000228	0.00328	CcSEcCtD
Betamethasone—Pruritus—Cyclosporine—focal segmental glomerulosclerosis	0.000225	0.00324	CcSEcCtD
Betamethasone—Diarrhoea—Cyclosporine—focal segmental glomerulosclerosis	0.000218	0.00313	CcSEcCtD
Betamethasone—Dizziness—Cyclosporine—focal segmental glomerulosclerosis	0.00021	0.00303	CcSEcCtD
Betamethasone—Vomiting—Cyclosporine—focal segmental glomerulosclerosis	0.000202	0.00291	CcSEcCtD
Betamethasone—Rash—Cyclosporine—focal segmental glomerulosclerosis	0.000201	0.00289	CcSEcCtD
Betamethasone—Dermatitis—Cyclosporine—focal segmental glomerulosclerosis	0.0002	0.00288	CcSEcCtD
Betamethasone—Headache—Cyclosporine—focal segmental glomerulosclerosis	0.000199	0.00287	CcSEcCtD
Betamethasone—Nausea—Cyclosporine—focal segmental glomerulosclerosis	0.000189	0.00272	CcSEcCtD
Betamethasone—PGR—Validated nuclear estrogen receptor alpha network—PCNA—focal segmental glomerulosclerosis	0.000124	0.0168	CbGpPWpGaD
Betamethasone—CYP19A1—Integrated Breast Cancer Pathway—PIAS1—focal segmental glomerulosclerosis	0.000122	0.0166	CbGpPWpGaD
Betamethasone—PTGS2—Overview of nanoparticle effects—FN1—focal segmental glomerulosclerosis	0.000122	0.0166	CbGpPWpGaD
Betamethasone—PTGS2—Calcium signaling in the CD4+ TCR pathway—CD40LG—focal segmental glomerulosclerosis	0.000112	0.0152	CbGpPWpGaD
Betamethasone—PTGS2—Prostaglandin Synthesis and Regulation—EDN1—focal segmental glomerulosclerosis	0.00011	0.015	CbGpPWpGaD
Betamethasone—PTGS2—Spinal Cord Injury—COL4A1—focal segmental glomerulosclerosis	9.15e-05	0.0124	CbGpPWpGaD
Betamethasone—NR3C1—BMAL1:CLOCK,NPAS2 activates circadian gene expression—SERPINE1—focal segmental glomerulosclerosis	7.85e-05	0.0107	CbGpPWpGaD
Betamethasone—PTGS2—Aryl Hydrocarbon Receptor—LPL—focal segmental glomerulosclerosis	7.6e-05	0.0103	CbGpPWpGaD
Betamethasone—NR3C1—AP-1 transcription factor network—EDN1—focal segmental glomerulosclerosis	7.38e-05	0.01	CbGpPWpGaD
Betamethasone—PTGS2—Signaling mediated by p38-alpha and p38-beta—NOS2—focal segmental glomerulosclerosis	7.38e-05	0.01	CbGpPWpGaD
Betamethasone—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CD40LG—focal segmental glomerulosclerosis	7.24e-05	0.00985	CbGpPWpGaD
Betamethasone—PLA2G1B—Metabolism of lipids and lipoproteins—LIPC—focal segmental glomerulosclerosis	6.82e-05	0.00928	CbGpPWpGaD
Betamethasone—NR3C1—FOXA2 and FOXA3 transcription factor networks—ALB—focal segmental glomerulosclerosis	6.82e-05	0.00927	CbGpPWpGaD
Betamethasone—PTGS2—Integrated Pancreatic Cancer Pathway—PIAS1—focal segmental glomerulosclerosis	6.77e-05	0.00921	CbGpPWpGaD
Betamethasone—NR3C2—Generic Transcription Pathway—CTGF—focal segmental glomerulosclerosis	6.53e-05	0.00889	CbGpPWpGaD
Betamethasone—NR3C1—AP-1 transcription factor network—AGT—focal segmental glomerulosclerosis	6.13e-05	0.00834	CbGpPWpGaD
Betamethasone—PLA2G1B—Metabolism of lipids and lipoproteins—CTGF—focal segmental glomerulosclerosis	6.01e-05	0.00817	CbGpPWpGaD
Betamethasone—NR3C1—Circadian Clock—SERPINE1—focal segmental glomerulosclerosis	5.72e-05	0.00777	CbGpPWpGaD
Betamethasone—ABCB1—Integrated Pancreatic Cancer Pathway—PIAS1—focal segmental glomerulosclerosis	4.8e-05	0.00653	CbGpPWpGaD
Betamethasone—PTGS2—Integrated Pancreatic Cancer Pathway—WT1—focal segmental glomerulosclerosis	4.47e-05	0.00608	CbGpPWpGaD
Betamethasone—NR3C1—Adipogenesis—LPL—focal segmental glomerulosclerosis	4.37e-05	0.00594	CbGpPWpGaD
Betamethasone—ABCB1—Allograft Rejection—AGTR1—focal segmental glomerulosclerosis	4.25e-05	0.00578	CbGpPWpGaD
Betamethasone—NR3C1—Regulation of nuclear SMAD2/3 signaling—SERPINE1—focal segmental glomerulosclerosis	4.19e-05	0.0057	CbGpPWpGaD
Betamethasone—PLA2G1B—Metabolism of lipids and lipoproteins—LPL—focal segmental glomerulosclerosis	4.16e-05	0.00566	CbGpPWpGaD
Betamethasone—ABCB1—HIF-1-alpha transcription factor network—EDN1—focal segmental glomerulosclerosis	4.16e-05	0.00565	CbGpPWpGaD
Betamethasone—PGR—Generic Transcription Pathway—CTGF—focal segmental glomerulosclerosis	3.98e-05	0.00541	CbGpPWpGaD
Betamethasone—NR3C1—Adipogenesis—AGT—focal segmental glomerulosclerosis	3.74e-05	0.00508	CbGpPWpGaD
Betamethasone—NR3C1—AP-1 transcription factor network—MMP9—focal segmental glomerulosclerosis	3.61e-05	0.00491	CbGpPWpGaD
Betamethasone—PLA2G1B—Metabolism of lipids and lipoproteins—AGT—focal segmental glomerulosclerosis	3.56e-05	0.00484	CbGpPWpGaD
Betamethasone—ABCB1—Allograft Rejection—CD40LG—focal segmental glomerulosclerosis	3.56e-05	0.00484	CbGpPWpGaD
Betamethasone—ABCB1—Integrated Pancreatic Cancer Pathway—WT1—focal segmental glomerulosclerosis	3.17e-05	0.00431	CbGpPWpGaD
Betamethasone—ABCB1—HIF-1-alpha transcription factor network—NOS2—focal segmental glomerulosclerosis	3.15e-05	0.00429	CbGpPWpGaD
Betamethasone—NR3C2—Gene Expression—CTGF—focal segmental glomerulosclerosis	3.15e-05	0.00428	CbGpPWpGaD
Betamethasone—NR3C1—Endoderm Differentiation—TGFB1—focal segmental glomerulosclerosis	3.05e-05	0.00414	CbGpPWpGaD
Betamethasone—PLA2G1B—Metabolism—LIPC—focal segmental glomerulosclerosis	3.04e-05	0.00413	CbGpPWpGaD
Betamethasone—NR3C2—Generic Transcription Pathway—SERPINE1—focal segmental glomerulosclerosis	2.98e-05	0.00405	CbGpPWpGaD
Betamethasone—NR3C1—AP-1 transcription factor network—TGFB1—focal segmental glomerulosclerosis	2.98e-05	0.00405	CbGpPWpGaD
Betamethasone—PTGS2—Selenium Micronutrient Network—SERPINE1—focal segmental glomerulosclerosis	2.97e-05	0.00404	CbGpPWpGaD
Betamethasone—PTGS2—Selenium Micronutrient Network—ALB—focal segmental glomerulosclerosis	2.97e-05	0.00404	CbGpPWpGaD
Betamethasone—NR3C1—Adipogenesis—SERPINE1—focal segmental glomerulosclerosis	2.87e-05	0.00391	CbGpPWpGaD
Betamethasone—PTGS2—Spinal Cord Injury—NOS2—focal segmental glomerulosclerosis	2.79e-05	0.0038	CbGpPWpGaD
Betamethasone—PLA2G1B—Metabolism of lipids and lipoproteins—ALB—focal segmental glomerulosclerosis	2.73e-05	0.00372	CbGpPWpGaD
Betamethasone—PLA2G1B—Metabolism—CTGF—focal segmental glomerulosclerosis	2.67e-05	0.00364	CbGpPWpGaD
Betamethasone—ABCB1—HIF-1-alpha transcription factor network—SERPINE1—focal segmental glomerulosclerosis	2.65e-05	0.00361	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism of lipids and lipoproteins—LIPC—focal segmental glomerulosclerosis	2.49e-05	0.00339	CbGpPWpGaD
Betamethasone—PLA2G1B—Metabolism—GNAQ—focal segmental glomerulosclerosis	2.46e-05	0.00335	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—COL4A4—focal segmental glomerulosclerosis	2.4e-05	0.00327	CbGpPWpGaD
Betamethasone—NR3C1—Generic Transcription Pathway—CTGF—focal segmental glomerulosclerosis	2.3e-05	0.00313	CbGpPWpGaD
Betamethasone—PTGS2—Integrated Pancreatic Cancer Pathway—PCNA—focal segmental glomerulosclerosis	2.26e-05	0.00308	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—COL4A1—focal segmental glomerulosclerosis	2.21e-05	0.003	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism of lipids and lipoproteins—CTGF—focal segmental glomerulosclerosis	2.19e-05	0.00298	CbGpPWpGaD
Betamethasone—PGR—Gene Expression—CTGF—focal segmental glomerulosclerosis	1.92e-05	0.00261	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—COL4A3—focal segmental glomerulosclerosis	1.87e-05	0.00254	CbGpPWpGaD
Betamethasone—PLA2G1B—Metabolism—LPL—focal segmental glomerulosclerosis	1.85e-05	0.00252	CbGpPWpGaD
Betamethasone—PGR—Generic Transcription Pathway—SERPINE1—focal segmental glomerulosclerosis	1.81e-05	0.00247	CbGpPWpGaD
Betamethasone—NR3C1—Adipogenesis—TGFB1—focal segmental glomerulosclerosis	1.81e-05	0.00247	CbGpPWpGaD
Betamethasone—PTGS2—Spinal Cord Injury—MMP9—focal segmental glomerulosclerosis	1.8e-05	0.00245	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism of lipids and lipoproteins—LIPC—focal segmental glomerulosclerosis	1.66e-05	0.00226	CbGpPWpGaD
Betamethasone—ABCB1—Integrated Pancreatic Cancer Pathway—PCNA—focal segmental glomerulosclerosis	1.6e-05	0.00218	CbGpPWpGaD
Betamethasone—PLA2G1B—Metabolism—AGT—focal segmental glomerulosclerosis	1.59e-05	0.00216	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism of lipids and lipoproteins—LPL—focal segmental glomerulosclerosis	1.52e-05	0.00207	CbGpPWpGaD
Betamethasone—PTGS2—Spinal Cord Injury—TGFB1—focal segmental glomerulosclerosis	1.48e-05	0.00202	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism of lipids and lipoproteins—CTGF—focal segmental glomerulosclerosis	1.47e-05	0.00199	CbGpPWpGaD
Betamethasone—ABCB1—Allograft Rejection—TGFB1—focal segmental glomerulosclerosis	1.45e-05	0.00197	CbGpPWpGaD
Betamethasone—NR3C2—Gene Expression—SERPINE1—focal segmental glomerulosclerosis	1.43e-05	0.00195	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—TRPC6—focal segmental glomerulosclerosis	1.37e-05	0.00187	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—AGTR2—focal segmental glomerulosclerosis	1.37e-05	0.00186	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism of lipids and lipoproteins—AGT—focal segmental glomerulosclerosis	1.3e-05	0.00177	CbGpPWpGaD
Betamethasone—PLA2G1B—Metabolism—ALB—focal segmental glomerulosclerosis	1.22e-05	0.00166	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—GNAQ—focal segmental glomerulosclerosis	1.15e-05	0.00156	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism—LIPC—focal segmental glomerulosclerosis	1.11e-05	0.00151	CbGpPWpGaD
Betamethasone—NR3C1—Gene Expression—CTGF—focal segmental glomerulosclerosis	1.11e-05	0.00151	CbGpPWpGaD
Betamethasone—ABCB1—Transmembrane transport of small molecules—TRPC6—focal segmental glomerulosclerosis	1.09e-05	0.00148	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	1.05e-05	0.00143	CbGpPWpGaD
Betamethasone—NR3C1—Generic Transcription Pathway—SERPINE1—focal segmental glomerulosclerosis	1.05e-05	0.00143	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism of lipids and lipoproteins—LPL—focal segmental glomerulosclerosis	1.02e-05	0.00138	CbGpPWpGaD
Betamethasone—PTGS2—Integrated Pancreatic Cancer Pathway—TGFB1—focal segmental glomerulosclerosis	1.01e-05	0.00137	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism of lipids and lipoproteins—ALB—focal segmental glomerulosclerosis	9.98e-06	0.00136	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism—CTGF—focal segmental glomerulosclerosis	9.77e-06	0.00133	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism—GNAQ—focal segmental glomerulosclerosis	9e-06	0.00122	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	8.9e-06	0.00121	CbGpPWpGaD
Betamethasone—PGR—Gene Expression—SERPINE1—focal segmental glomerulosclerosis	8.74e-06	0.00119	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism of lipids and lipoproteins—AGT—focal segmental glomerulosclerosis	8.69e-06	0.00118	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—LPL—focal segmental glomerulosclerosis	8.64e-06	0.00117	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	8.18e-06	0.00111	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—LIPC—focal segmental glomerulosclerosis	7.41e-06	0.00101	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—AGT—focal segmental glomerulosclerosis	7.39e-06	0.001	CbGpPWpGaD
Betamethasone—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—focal segmental glomerulosclerosis	7.16e-06	0.000974	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—FN1—focal segmental glomerulosclerosis	6.83e-06	0.000928	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism—LPL—focal segmental glomerulosclerosis	6.77e-06	0.000921	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism of lipids and lipoproteins—ALB—focal segmental glomerulosclerosis	6.67e-06	0.000907	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—CTGF—focal segmental glomerulosclerosis	6.53e-06	0.000887	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—GNAQ—focal segmental glomerulosclerosis	6.01e-06	0.000818	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism—AGT—focal segmental glomerulosclerosis	5.79e-06	0.000788	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	5.68e-06	0.000772	CbGpPWpGaD
Betamethasone—PTGS2—Disease—LPL—focal segmental glomerulosclerosis	5.4e-06	0.000735	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—LIPC—focal segmental glomerulosclerosis	5.25e-06	0.000715	CbGpPWpGaD
Betamethasone—NR3C1—Gene Expression—SERPINE1—focal segmental glomerulosclerosis	5.05e-06	0.000687	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—CTGF—focal segmental glomerulosclerosis	4.63e-06	0.000629	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—LPL—focal segmental glomerulosclerosis	4.52e-06	0.000615	CbGpPWpGaD
Betamethasone—ABCB1—Transmembrane transport of small molecules—ALB—focal segmental glomerulosclerosis	4.49e-06	0.000611	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism—ALB—focal segmental glomerulosclerosis	4.44e-06	0.000604	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	4.35e-06	0.000592	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—GNAQ—focal segmental glomerulosclerosis	4.26e-06	0.00058	CbGpPWpGaD
Betamethasone—PTGS2—Disease—NOS2—focal segmental glomerulosclerosis	4.22e-06	0.000574	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—AGT—focal segmental glomerulosclerosis	3.87e-06	0.000526	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	3.59e-06	0.000488	CbGpPWpGaD
Betamethasone—PTGS2—Disease—SERPINE1—focal segmental glomerulosclerosis	3.55e-06	0.000483	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—LIPC—focal segmental glomerulosclerosis	3.24e-06	0.00044	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—LPL—focal segmental glomerulosclerosis	3.21e-06	0.000436	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—ALB—focal segmental glomerulosclerosis	2.97e-06	0.000404	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—CTGF—focal segmental glomerulosclerosis	2.85e-06	0.000388	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—AGT—focal segmental glomerulosclerosis	2.74e-06	0.000373	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—GNAQ—focal segmental glomerulosclerosis	2.63e-06	0.000357	CbGpPWpGaD
Betamethasone—PTGS2—Disease—TGFB1—focal segmental glomerulosclerosis	2.24e-06	0.000305	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—ALB—focal segmental glomerulosclerosis	2.11e-06	0.000286	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—LPL—focal segmental glomerulosclerosis	1.98e-06	0.000269	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—AGT—focal segmental glomerulosclerosis	1.69e-06	0.00023	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—ALB—focal segmental glomerulosclerosis	1.3e-06	0.000176	CbGpPWpGaD
